Bone-only oligometastatic renal cell carcinoma patients treated with stereotactic body radiotherapy: a multi-institutional study

被引：0
|
作者：
Cem Onal
Ozan Cem Guler
Pervin Hurmuz
Guler Yavas
Burak Tilki
Ezgi Oymak
Cagdas Yavas
Gokhan Ozyigit
机构：
[1] Adana Dr. Turgut Noyan Research and Treatment Center,Department of Radiation Oncology
[2] Baskent University Faculty of Medicine,Department of Radiation Oncology
[3] Hacettepe University Faculty of Medicine,Department of Radiation Oncology
[4] Baskent University Faculty of Medicine,Division of Radiation Oncology
[5] Iskenderun Gelisim Hospital,undefined
来源：
Strahlentherapie und Onkologie | 2022年 / 198卷
关键词：
Renal cell carcinoma; Bone metastasis; Oligometastasis; Stereotactic body radiotherapy; Radiotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：940 / 948
页数：8
相关论文
共 50 条
  • [21] Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intent
    Buglione, Michela
    Jereczek-Fossa, Barbara Alicja
    Bonu, Marco Lorenzo
    Franceschini, Davide
    Fodor, Andrei
    Zanetti, Isa Bossi
    Gerardi, Marianna Alessandra
    Borghetti, Paolo
    Tomasini, Davide
    Di Muzio, Nadia Gisella
    Oneta, Olga
    Scorsetti, Marta
    Franzese, Ciro
    Romanelli, Paola
    Catalano, Giampiero
    Dell'Oca, Italo
    Beltramo, Giancarlo
    Ivaldi, Giovanni Battista
    Laudati, Antonio
    Magrini, Stefano Maria
    Antognoni, Paolo
    LUNG CANCER, 2020, 141 : 1 - 8
  • [22] The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma
    Ali, Muhammad
    Mooi, Jennifer
    Lawrentschuk, Nathan
    Mckay, Rana R.
    Hannan, Raquibul
    Lo, Simon S.
    Hall, William A.
    Siva, Shankar
    EUROPEAN UROLOGY, 2022, 82 (06) : 613 - 622
  • [23] Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis
    Ost, Piet
    Jereczek-Fossa, Barbara Alicja
    Van As, Nicholas
    Zilli, Thomas
    Muacevic, Alexander
    Olivier, Kenneth
    Henderson, Daniel
    Casamassima, Franco
    Orecchia, Roberto
    Surgo, Alessia
    Brown, Lindsay
    Tree, Alison
    Miralbell, Raymond
    De Meerleer, Gert
    EUROPEAN UROLOGY, 2016, 69 (01) : 9 - 12
  • [24] Whether Primary Bone-Only Oligometastatic Nasopharyngeal Carcinoma Patients Benefit From Radiotherapy to the Bones on the Basis of Palliative Chemotherapy Plus Locoregional Radiotherapy?-A Large-Cohort Retrospective Study
    Guo, Wan-Ping
    Jia, Guo-Dong
    Xie, Si-Yi
    Yu, Xuan
    Meng, Xiao-Han
    Tang, Lin-Quan
    Li, Xiao-Yun
    Luo, Dong-Hua
    CANCER MEDICINE, 2024, 13 (21):
  • [25] Stereotactic body radiotherapy (SBRT)/stereotactic ablative body radiotherapy (SABR) for "radioresistant" renal cell carcinoma (RCC)
    Ishiyama, Hiromichi
    Blanco, Angel I.
    Lo, Simon S.
    Butler, E. Brian
    Teh, Bin S.
    JOURNAL OF RADIATION ONCOLOGY, 2014, 3 (04) : 339 - 346
  • [26] Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis; [Rezidivmuster nach stereotaktischer Radiotherapie beim oligometastasierten Prostatakarzinom: eine multiinstitutionelle Analyse]
    Nicosia L.
    Franzese C.
    Mazzola R.
    Franceschini D.
    Rigo M.
    D’agostino G.
    Corradini S.
    Alongi F.
    Scorsetti M.
    Strahlentherapie und Onkologie, 2020, 196 (3) : 213 - 221
  • [27] Multi-institutional analysis of early squamous cell carcinoma of the hypopharynx treated with radical radiotherapy
    Nakamura, Katsumasa
    Shioyama, Yoshiyuki
    Kawashima, Mitsuhiko
    Saito, Yoshihiro
    Nakamura, Naoki
    Nakata, Kensei
    Hareyama, Masato
    Takada, Takahiro
    Karasawa, Kumiko
    Watanabe, Toshiichi
    Yorozu, Atsunori
    Tachibana, Hiroyuki
    Suzuki, Gen
    Hayabuchi, Naofumi
    Toba, Takashi
    Yamada, Shogo
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (04): : 1045 - 1050
  • [28] Metabolic factors associated with the prognosis of oligometastatic patients treated with stereotactic body radiotherapy
    Klement, Rainer J.
    Sweeney, Reinhart A.
    CANCER AND METASTASIS REVIEWS, 2023, 42 (03) : 927 - 940
  • [29] Metabolic factors associated with the prognosis of oligometastatic patients treated with stereotactic body radiotherapy
    Rainer J. Klement
    Reinhart A. Sweeney
    Cancer and Metastasis Reviews, 2023, 42 : 927 - 940
  • [30] A multi-institutional phase 2 trial of stereotactic body radiotherapy in the treatment of bone metastases in pediatric and young adult patients with sarcoma
    Elledge, Christen R.
    Krasin, Matthew J.
    Ladra, Matthew M.
    Alcorn, Sara R.
    Han, Peijin
    Gibbs, Iris C.
    Hiniker, Susan M.
    Laack, Nadia N.
    Terezakis, Stephanie A.
    CANCER, 2021, 127 (05) : 739 - 747
12345